We create value.
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.

We create value.

Aktiedata

AXICHEM A
(AXIC A)
High
20.1
Low
19.45
Volume
4927
Turnover
97821.5
Read more
January 27, 2022 11:01:38
Financial Reports
Financial Reports
No results

Financial Calendar

Year-end report 2021 - 17 February 2022

Annual Report 2021 - 10 May 2022

Interim report 1/2022 - 24 May 2022

Annual general meeting 2022 - 31 May 2022

Interim report 2/2022 - 25 August 2022

Interim report 3/2021 - 24 November 2022

Year-end report 2022 - 23 February 2023

All Press Releases
Regulatory Press Releases
No results

Commissioned Research
September 09, 2021
aXichem Update – Entering the Commercial Phase september 2021
Redeye
Company description

We draw from the genius of nature and respect nature in return.

Corporate Governance

Prospectus

aXichem prospekt 2019
pdf 9.55 MB
Memorandum aXichem 2016
pdf 3.37 MB
aXichem prospekt 2015
pdf 4.53 MB

Meetings Archive

Protokoll stämma 2021
pdf 2.08 MB
Kallelse stämma 2021
pdf 541.87 KB
Kommuniké stämma 2021
pdf 121.92 KB
Protokoll stämma 2020
pdf 268.31 KB
Kommuniké stämma 2020
pdf 514.45 KB
Kallelse stämma 2020
pdf 55.46 KB
Fullmaktsformulär 2019
pdf 34.75 KB
Kallelse till årsstämma i aXichem 2019
pdf 86.71 KB
Protokoll stämma 2018
pdf 775.25 KB
Årsredovisning 2017
pdf 6.48 MB
Fullmaktsformulär
pdf 206.00 KB
Kallelse stämma 2018
pdf 62.98 KB
Kallelse stämma 2017
pdf 219.08 KB
Fullmaktsformulär
pdf 29.26 KB
Årsredovisning 2016 för aXichem AB
pdf 6.64 MB
Fullmaktsformulär
pdf 328.53 KB
Styrelsens förslag till beslut om bemyndigande
pdf 21.17 KB
Kallelse stämma 2016
pdf 52.19 KB
Kallelse stämma 2015
pdf 101.92 KB
Kallelse stämma 2014
pdf 148.06 KB
Kommuniké stämma 2013
pdf 68.63 KB
Kallelse stämma 2013
pdf 178.91 KB
Kommuniké stämma 2012
pdf 330.61 KB
Kallelse stämma 2012
pdf 324.54 KB
Kommuniké stämma 2011
pdf 175.42 KB
Kallelse stämma 2011
pdf 270.76 KB
Kommuniké stämma 2010
pdf 38.08 KB
Kallelse stämma 2010
pdf 49.63 KB
Kommuniké stämma 2009
pdf 51.81 KB
Kallelse stämma 2009
pdf 66.03 KB

Financial Advisor and Certified Advisor

Redeye AB
Box 7141
103 87 Stockholm
08-545 013 30
www.redeye.se
certifiedadviser@redeye.se

Corporate Governance

We create value.

Investor Structure

Largest owners as of 30 September 2021 aXichem’s ten largest owners according to the shareholders’ register kept by Euroclear

 

Name No. of shares Participating interest (%)
Manakin Ltd 1 842 055 11,14
LMK -bolagen 1 806 864 10,93
Försäkringsaktiebolaget Avanza Pension  1 144 836  6,92
Nordnet Pensionsförsäkring AB    675 147  4,08
Pension Futur    580 274  3,51
Vasilis, Per   353 047  2,14
Kraft, Rolf   331 782  2,01
Redoterm AB   318 947  1,93
Fladvad, Per   191 026  1,16
Berger, Gunnar   185 656  1,12

 

Investor enquiries

Subscribe to information from Axichem via First North.
Subscription Feed*

Language*

Name Surname*

E-mail*

Company Name

SMS (+46709123456)